Healthcare and Tech Lead SP 500 to Modest Gains as Communication Services Lags Dekiln Partners with Johnson Tiles to Scale LowCarbon Recycled Tile Production in UK Ceramics Revival Dow Leads Wall Street Higher as Healthcare and Tech Stocks Rally US Employment Surges Past Forecasts Amid Warning Signs in Labor Market Data Meren Energy Backs Impact Oil Gas Restructuring to Focus on Namibia Venus FID Lithuania Data Breach Exposes 600000 National Records Spy Addresses at Risk IO Biotech Q3 2025 Earnings EPS Beat of 6067 Surprise but No Revenue from PreCommercial Pipeline ESTA Q1 2026 Earnings WiderthanExpected Loss Reflects RD and Commercial Investments ARWR Q1 2026 Earnings Adjusted Loss Narrows Shares Rise on Surprise Beat General Mills Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Persist Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline Dominari Holdings Inc DOMH Q1 2024 Earnings Reports GAAP Loss of 035 Per Share Amid Flat Revenue EVT Edges Lower as TaxAdvantaged Dividend Fund Tests Neutral Territory Jena Acquisition Corporation II JENA Holds Steady Near Resistance as SPAC Market Watches for Catalysts Westin Acquisition Corp WSTN Holds Steady at 1008 Amid Quiet Trading AMETEK Inc AME Rallies 216 as Price Approaches Key Resistance Near 241 International General Insurance Holdings IGIC Faces Resistance Slips 266 on Lower Volume NLY Q1 2026 Earnings Slight EPS Beat Amid Mortgage Market Shifts MSDL Q1 2026 Earnings Small EPS Beat Meets Modest Market Pullback HWM Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Aerospace Demand FLNC Q1 2026 Earnings Slightly BetterThanExpected Loss Drives Positive Market Reaction NN Inc Q1 2026 Earnings Surprise Profitability Surges on Cost Controls Edison International EIX Q1 2026 Earnings EPS Beats Estimates by 712 as Utility Operations Strengthen Balcony Solar Panels Gain Traction as US Electricity Prices Surge ALZN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Management Amid PreRevenue Phase Eupraxia Pharmaceuticals EPRX Gains 279 as Stock Tests Resistance Near 775